Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe

Salahudeen, Ameen A.; Patel, Manali I.; Baas, Paul; Bradley, Jeffrey D.; Gandara, David R.; Goss, Glenwood D.; Mok, Tony; Ramalingam, Suresh S.; Vokes, Everett E.; Malik, Shakun; Wakelee, Heather A.

doi:10.1016/j.cllc.2016.06.007

Cited by 3 publications

(2 citation statements)

References 17 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The full schema of the Lung-MAP study was discussed at the 16th ILCC meeting and described in our previous review. 2 The current updated schema is shown in Figure 3. In adenocarcinoma, despite the relative abundance of targeted options, KRAS, the most common driver oncogene, remains an elusive target.…”

Section: Advanced-stage Diseasementioning

confidence: 99%

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Shukla

Salahudeen

Taylor

et al. 2018

Clinical Lung Cancer

Self Cite

View full text Add to dashboard Cite

Cancer cooperative groups have historically played a critical role in the advancement of nonesmall-cell lung cancer therapy. Representatives from cooperative groups worldwide convene at the International Lung Cancer Congress annually. The International Lung Cancer Congress had its 17th anniversary in the summer of 2016. The present review highlights the thoracic malignancy studies discussed by presenters. The included studies are merely a sample of the trials of thoracic malignancies ongoing globally.

show abstract

Section: Advanced-stage Diseasementioning

confidence: 99%

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Shukla

Salahudeen

Taylor

et al. 2018

Clinical Lung Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…1,2 To conduct these trials, these fields, namely cardiology and oncology, have devised an infrastructure to support large studies. 3,4 Palliative care has had neither the infrastructure nor scientific workforce to answer many important questions relevant to improving care for those with serious illness and their caregivers. The National Institute for Nursing Research (NINR) funded the Palliative Care Research Cooperative (PCRC) to address this need.…”

Section: Introductionmentioning

confidence: 99%

Better Together: The Making and Maturation of the Palliative Care Research Cooperative Group

Ritchie

Pollak

Kehl

et al. 2017

Journal of Palliative Medicine

View full text Add to dashboard Cite

Objective: To describe the growth and outcomes of the Palliative Care Research Cooperative Group (PCRC). Background: Despite advances, significant gaps remain in the evidence base to inform care for people with serious illness. To generate this needed evidence and bolster research capacity, the Palliative Care Research Cooperative (PCRC) group was formed. Methods: The PCRC supports investigators in the conduct of multisite clinical studies. After developing a governance structure and completing a proof of concept demonstration study, the PCRC expanded its infrastructure to include additional resource cores (Clinical Studies; Measurement; Data Informatics and Statistics; and Caregiver Studies). The PCRC also supports an Investigator Development Center as many palliative care investigators valued opportunities to advance their skills. Additional key aspects of PCRC resources include a Scientific Review Committee, a Publications Committee, and initiatives to purposefully engage investigators in a community of palliative care science. Results: The PCRC has grown to over 300 members representing more than 130 distinct sites. To date, the PCRC has supported the submission of 51 research applications and has engaged in 27 studies. The PCRC supports investigator research development needs through webinars and clinical trials ''intensives.'' To foster a sense of community, the PCRC has convened biannual meetings, developed special interest groups, and regularly communicates via a newsletter and its website. Conclusion: With a particular focus on facilitating conduct of rigorous multisite clinical studies, the PCRC fosters an engaged multidisciplinary research community, filling an important void in generating and disseminating evidence that informs the provision of high-quality care to people with serious illness.

show abstract

Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries

Créquit

Vivot

Grégory

et al. 2022

Journal of Cancer Policy

View full text Add to dashboard Cite

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe

Cited by 3 publications

References 17 publications

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Better Together: The Making and Maturation of the Palliative Care Research Cooperative Group

Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries

Contact Info

Product

Resources

About